NGM Biopharmaceuticals Inc (OQ:NGM)

Business Focus: Bio Therapeutic Drugs

Apr 08, 2019 16:30 ET
NGM Bio Announces Multiple Presentations at The International Liver Congress™ 2019
NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a clinical stage biotechnology company focused on harnessing powerful biology to develop transformative therapeutics for patients, today announced multiple presentations at European Association for the...
Apr 03, 2019 20:58 ET
NGM Bio Announces Pricing of Initial Public Offering
NGM Biopharmaceuticals, Inc. (“NGM”) today announced the pricing of its initial public offering of 6,666,667 shares of common stock at a price to the public of $16.00 per share. In addition, NGM has granted the underwriters a 30-day option to...